Summary
Serum copper and ceruloplasmin levels are known to increase in several malignancies such as osteosarcomas, some gastrointestinal tumors, and lung cancer. In this study serum copper and ceruloplasmin levels in 40 patients with primary brain tumors were studied. Both parameters were increased in sera of patients with tumors in comparison with healthy subjects or patients with non-tumorous neurological diseases. It is concluded that copper and ceruloplasmin represent a good complement to some other nonspecific parameters in evaluating the activity of malignancy and the therapeutic results.
This is a preview of subscription content, log in via an institution to check access.
References
Breiter DN, Diasio RB, Neifeld JP, Roush ML, Rosemberg SA (1978) Serum copper and zinc measurements in patients with osteogenic sarcoma. Cancer 42:598–602
Canelas HM, DeJorge FB, Pereira WC, Sallum J (1968) Biochemistry of cerebral tumours. Sodium, potassium, calcium, phosphorus, magnesium, copper and sulphur contents of astrocytoma, medulloblastoma and glioblastoma multiforme. J Neurochem 15:1455–1461
Fisher GL (1975) Function and homeostasis of copper and zinc in mammals. Sci. Total Environ 4:373–412
Fisher GL, Shifrine M (1978) Hypothesis for the mechanism of elevated serum copper in cancer patients. Oncology 35:22–25
Frieden E (1973) The ferrous to ferric cycles in iron metabolism. Nutr Rev 31:41–44
Gubler CJ, Lahey ME, Cartwright CE, Wintrobe MM (1953) The transportation of copper in blood. J Clin Invest 32:405–413
Hrgovcic M, Tessmer CR, Thomas FB, Fuller ML, Gamble GF, Shullenberger CC (1973) Significance of serum copper level in adult patients with Hodgkin's disease. Cancer 31:1337–1345
Jurga Ľ, Wagnerová M, Klvaňa M, Matula P (1978) Cupremia and sideremia in the course of radiochemotherapy in malignant lymphomas. Vnitr Lek 24:351–357
Kaiser J, Gullotta F (1980) Estimation of the copper content of astrocytomas, and glioblastomas by the cuproin method. Neurochirurgia 23:20–23
Kessel D, Allen J (1975) Elevated plasma sialyltransferase in the cancer patient. Cancer Res 35:670–672
Kolaric K, Roguljic A, Fuss V (1975) Serum copper levels in patients with solid tumors. Tumori 61:173–177
Masi M, Vecchi V, Vivarelli F, Paolucci P (1975) La ceruloplasminemia nella leucosi acuta linfoblastica e nel morbo di Hodgkin dell'infanzia. Minerva Pediatr 22:1223–1227
Pizzolo G, Savarin T, Molino AM, Ambosetti A, Todeschini G, Vettore L (1978) The diagnostic value of serum copper levels and other hematochemical parameters in malignancies. Tumori 64:55–61
Přibyl T (1978) Serum polyphenol oxidase activity (ceruloplasmin) in conventional laboratory animals and man. Folia Biol (Praha) 24:136–141
Scanni A, Tomirotti M, Licciardello L, Annibali E, Biraghi M, Trovato M, Fittipaldi M, Adamoli P, Curtarello G (1979) Variations in serum copper and ceruloplasmin levels in advanced gastrointestinal cancer treated with polychemotherapy. Tumori 65:331–338
Schreiber V, Přibyl T, Belikovová H (1975) Ceruloplasmin in the serum of patients with cancer of mammary gland. Cas Lek Cesk 114:906–907
Schreiber V, Přibyl T (1976) Ceruloplasmin. Cesk Fysiol 25:97–114
Shifrine M, Fisher GL (1976) Ceruloplasmin levels in serum from human patients with osteosarcoma. Cancer 38:244–248
Van Den Hamer JA, Morrell AG, Scheinberg IH, Hickman J, Ashwell G (1970) The role of galactosyl residues in the clearance of ceruloplasmin from the circulation. J Biol Chem 245:4397–4402
Wollemann M (1974) Biochemistry of brain tumors. Mac-Millans Press Ltd, London
Zak B, Ressler N (1956) Simultaneous microdetermination of copper and iron using mixed phenantrolines. Anal Chem 28:1158–1161
Rights and permissions
About this article
Cite this article
Turecký, L., Kalina, P., Uhlíková, E. et al. Serum ceruloplasmin and copper levels in patients with primary brain tumors. Klin Wochenschr 62, 187–189 (1984). https://doi.org/10.1007/BF01731643
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01731643